Author

E. Conroy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Buckley· 1 shared B. N. Kennedy· 1 shared C. T. Butler· 1 shared J. O'Sullivan· 1 shared R. Doyle· 1 shared S. Kennedy· 1 shared W. M. Gallagher· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Buckley

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

1,4-dihydroxy Quininib Attenuates Growth of Colorectal Cancer Cells and Xenografts and Regulates the TIE-2 Signaling Pathway in Patient Tumours

C. T. Butler, S. Kennedy, A. Buckley, R. Doyle, E. Conroy, W. M. Gallagher, J. O'Sullivan, B. N. Kennedy

This study shows that Q8, a modified quininib, inhibits colorectal cancer growth and angiogenesis by targeting the TIE-2 signaling pathway in both cell and xenograft models.

bioRxiv · Dec 21, 2018Cancer Biology